• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Clin Epidemiol . Predicting COVID-19 prognosis in the ICU remained challenging: external validation in a multinational regional cohort

tetano

Editor, Senior Moderator
J Clin Epidemiol


. 2022 Oct 26;S0895-4356(22)00265-7.
doi: 10.1016/j.jclinepi.2022.10.015. Online ahead of print.
Predicting COVID-19 prognosis in the ICU remained challenging: external validation in a multinational regional cohort


Daniek A M Meijs[SUP] 1 [/SUP], Sander M J van Kuijk[SUP] 2 [/SUP], Laure Wynants[SUP] 3 [/SUP], Björn Stessel[SUP] 4 [/SUP], Jannet Mehagnoul-Schipper[SUP] 5 [/SUP], Anisa Hana[SUP] 6 [/SUP], Clarissa I E Scheeren[SUP] 7 [/SUP], Dennis C J J Bergmans[SUP] 8 [/SUP], Johannes Bickenbach[SUP] 9 [/SUP], Margot Vander Laenen[SUP] 10 [/SUP], Luc J M Smits[SUP] 2 [/SUP], Iwan C C van der Horst[SUP] 11 [/SUP], Gernot Marx[SUP] 9 [/SUP], Dieter Mesotten[SUP] 12 [/SUP], Bas C T van Bussel[SUP] 13 [/SUP], CoDaP investigators[SUP] 14 [/SUP]



Collaborators, Affiliations

Abstract

Objective: Many prediction models for Coronavirus Disease 2019 (COVID-19) have been developed. External validation is mandatory before implementation in the Intensive Care Unit (ICU). We selected and validated prognostic models in the Euregio Intensive Care COVID (EICC) cohort.
Study design and setting: In this multinational cohort study, routine data from COVID-19 patients admitted to ICUs within the Euregio Meuse-Rhine were collected from March to August 2020. COVID-19 models were selected based on model type, predictors, outcomes, and reporting. Furthermore, general ICU scores were assessed. Discrimination was assessed by area under the receiver operating characteristic curves (AUCs) and calibration by calibration-in-the-large and calibration plots. A random-effects meta-analysis was used to pool results.
Results: 551 patients were admitted. Mean age was 65.4±11.2 years, 29% were female, and ICU mortality was 36%. Nine out of 238 published models were externally validated. Pooled AUCs were between 0.53 and 0.70 and calibration-in-the-large between -9% and 6%. Calibration plots showed generally poor but, for the 4C Mortality score and SEIMC score, moderate calibration.
Conclusion: Of the nine prognostic models that were externally validated in the EICC cohort, only two showed reasonable discrimination and moderate calibration. For future pandemics, better models based on routine data are needed to support admission decision-making.

Keywords: COVID-19; Critical Care; Intensive Care Unit; Prediction; Prognosis; SARS-CoV-2.
 
Back
Top Bottom